About MedReleaf (TSE:LEAF)
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.
Industry, Sector and Symbol
Trailing P/E Ratio945
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-6.38%
Return on Assets-5.47%
MedReleaf (TSE:LEAF) Frequently Asked Questions
What is MedReleaf's stock symbol?
MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF."
Where is MedReleaf's stock going? Where will MedReleaf's stock price be in 2018?
2 brokers have issued twelve-month price objectives for MedReleaf's shares. Their forecasts range from C$20.00 to C$36.00. On average, they expect MedReleaf's stock price to reach C$28.67 in the next twelve months. View Analyst Ratings for MedReleaf.
Who are some of MedReleaf's key competitors?
Some companies that are related to MedReleaf include Stantec (STN), B2Gold (BTO), Allied Properties Real Estate Investment (AP.UN), Domtar (UFS), Genworth MI Canada (MIC), Brookfield Residential Properties (BRP), New Flyer Industries (NFI), Canadian REIT (REF.UN), Cogeco Communications (CCA), Maxar Technologies (MAXR), Enerplus (ERF), Premium Brands (PBH), Chartwell Retirement Residences (CSH.UN), Colliers International Group (CIG), Stella-Jones (SJ), Colliers International Group (CIGI), Yamana Gold (YRI) and Whitecap Resources (WCP).
Who are MedReleaf's key executives?
MedReleaf's management team includes the folowing people:
- Eitan Popper, President (Age 35)
- Neil Closner, Chief Executive Officer, Executive Director
- Igor Gimelshtein, Chief Financial Officer, Corporate Secretary
- Angelo Fefekos, Vice President - Clinical Affairs and Quality Compliance
- Darren Karasiuk, Vice President - Strategy
- Ivan Latysh, Vice President - Information Technology
- Lloyd M. Segal, Non-Executive Chairman of the Board (Age 51)
- Norma Beauchamp, Non-Executive Director
- Ronald Funk, Non-Executive Director
- Deborah E. Rosati, Non-Executive Director (Age 55)
Has MedReleaf been receiving favorable news coverage?
Media stories about LEAF stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. MedReleaf earned a media sentiment score of 0.10 on Accern's scale. They also gave news stories about the company an impact score of 45.93 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of MedReleaf?
Shares of LEAF and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is MedReleaf's stock price today?
One share of LEAF stock can currently be purchased for approximately C$18.90.
How big of a company is MedReleaf?
MedReleaf has a market capitalization of C$1.91 billion.
MarketBeat Community Rating for MedReleaf (LEAF)MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for MedReleaf (TSE:LEAF)
No earnings announcements for this company have been tracked by MarketBeat.com
MedReleaf (TSE:LEAF) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for MedReleaf (TSE:LEAF)
No dividend announcements for this company have been tracked by MarketBeat.com
MedReleaf (TSE LEAF) Insider Trading and Institutional Ownership History
MedReleaf (TSE LEAF) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/29/2018||Olam Ltd. Tikun||Insider||Sell||1,000,000||C$22.02||C$22,020,000.00|
|1/25/2018||Olam Ltd. Tikun||Insider||Sell||28,600||C$25.00||C$715,000.00|
|1/23/2018||Olam Ltd. Tikun||Insider||Sell||29,300||C$25.00||C$732,500.00|
MedReleaf (TSE LEAF) News Headlines
|MedReleaf signs supply agreement with Cannamedical Pharma GmbH in Germany|
finance.yahoo.com - March 19 at 3:22 PM
|Data Projects What Cannabis Market Could Look Like Under Full Federal Legalization - PR Newswire (press release)|
www.prnewswire.com - March 16 at 3:17 PM
|Ray Leach Sells 100,000 Shares of MedReleaf Corp (LEAF) Stock|
www.americanbankingnews.com - March 12 at 2:02 PM
|5 Marijuana Stocks With the Highest Production Capacity - Motley Fool|
www.fool.com - March 9 at 3:24 PM
|Marijuana Stocks That Do This Will Probably Be the Most Profitable ... - Motley Fool|
www.fool.com - March 7 at 5:30 AM
|MedReleaf adds the iconic Woodstock brand to its recreational market portfolio|
finance.yahoo.com - March 6 at 8:26 AM
|Ray Leach Sells 19,600 Shares of MedReleaf Corp (LEAF) Stock|
www.americanbankingnews.com - March 4 at 12:10 AM
|MedReleaf Corp (LEAF) Insider Sells C$1,559,112.00 in Stock|
www.americanbankingnews.com - March 4 at 12:10 AM
|MedReleaf to purchase 164 acre property, including 1 million square feet of existing greenhouse to add an additional 105,000 kg of fully funded capacity output|
finance.yahoo.com - February 26 at 7:15 AM
|MedReleaf Corp. Returns to Growth — and Potential Acquisitions - The Motley Fool Canada|
www.fool.ca - February 16 at 3:18 PM
|Pot Pharm: Booming Canada weed sector plots next-wave medicines|
www.reuters.com - February 16 at 6:31 AM
|Pot Pharm - Booming Canada weed sector plots next-wave medicines|
finance.yahoo.com - February 16 at 6:31 AM
|Recreational marijuana sales in Canada face fresh delays|
finance.yahoo.com - February 16 at 6:31 AM
|MedReleaf (LEAF) PT Raised to C$30.00|
www.americanbankingnews.com - February 14 at 3:12 PM
|MedReleaf Reports Third Quarter Fiscal 2018 Results|
finance.yahoo.com - February 13 at 3:15 PM
|MedReleaf Corp (LEAF) Insider Sells C$659,166.00 in Stock|
www.americanbankingnews.com - February 12 at 6:30 PM
|MedReleaf Corp. Launches Recreational Cannabis Brand: San Rafael '71 - The Motley Fool Canada|
www.fool.ca - February 12 at 3:15 PM
|Stephen Arbib Sells 50,600 Shares of MedReleaf Corp (LEAF) Stock|
www.americanbankingnews.com - February 9 at 3:30 PM
|MedReleaf introduces first adult-use recreational cannabis brand: San Rafael '71 launches with cannabis-inspired beer|
finance.yahoo.com - February 9 at 3:15 PM
|Marijuana can only go on sale in Canada months after law passed -minister|
finance.yahoo.com - February 7 at 5:15 AM
|MedReleaf receives Health Canada approval for cannabis oil softgel capsules|
finance.yahoo.com - February 6 at 3:15 PM
|MedReleaf Corp. Announces Closing of Previously Announced Offering|
finance.yahoo.com - January 31 at 3:15 PM
|Insider Selling: MedReleaf Corp (LEAF) Insider Sells 1,000,000 Shares of Stock|
www.americanbankingnews.com - January 30 at 3:12 PM
|Tikun Olam Announces Holdings in MedReleaf Corporation|
finance.yahoo.com - January 30 at 3:11 PM
|MedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 28,600 Shares|
www.americanbankingnews.com - January 29 at 3:14 PM
|MedReleaf Corp. to Host Third Quarter Fiscal 2018 Conference Call|
finance.yahoo.com - January 29 at 3:13 PM
|Cannabis Stocks Begin To Reflect The Real Industry|
finance.yahoo.com - January 28 at 3:15 PM
|Better Marijuana Stock: Aphria vs. MedReleaf -- The Motley Fool - Motley Fool|
www.fool.com - January 28 at 5:16 AM
|MedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 29,300 Shares|
www.americanbankingnews.com - January 25 at 9:28 PM
|Make it or Break it: Here are 3 of the Most Exciting Stocks Available Today|
www.fool.ca - January 25 at 3:12 PM
|BMO Open to More Pot Deals If Firms Pass Bank's Tests, CEO Says - Bloomberg|
www.bloomberg.com - January 25 at 3:12 PM
|Cannabis Industry Group Announces National Standards, Starts With Marijuana Product Packaging And Labeling - Benzinga|
www.benzinga.com - January 25 at 5:15 AM
|It's High Times for Pot Deals in Canada Ahead of Legalization - Bloomberg|
www.bloomberg.com - January 24 at 3:15 PM
|MedReleaf Ready To Rumble: Positioned Well For Long-Term Growth - Seeking Alpha|
seekingalpha.com - January 23 at 3:17 PM
|Before BMO led stock sale for marijuana grower, CIBC lent money - The Globe and Mail|
www.theglobeandmail.com - January 20 at 3:18 PM
|Standout Canadian Players Foster 'the Cannabis Lifestyle' - PR Newswire (press release)|
www.prnewswire.com - January 17 at 8:45 AM
|BRIEF-Medreleaf Announces Upsize Of Previously Announced Offering|
www.reuters.com - January 9 at 5:58 PM
|MedReleaf Corp. Announces Upsize of Previously Announced Offering|
finance.yahoo.com - January 9 at 5:58 PM
|MedReleaf (LEAF) PT Raised to C$36.00|
www.americanbankingnews.com - January 8 at 2:36 PM
|California Legalization Has Canadian Pot Stocks Smoking|
www.bloomberg.com - January 2 at 7:24 PM
|Modern Leaf Partners with mdBriefCase Group Inc. and Advancing Practice; Secures Strategic Investment to Launch Cannabis Education and Proposed Ecommerce Platform|
finance.yahoo.com - December 18 at 9:08 AM
|Why it’s so difficult to bet against Canada’s marijuana boom|
www.theglobeandmail.com - December 15 at 9:17 AM
|Why It's So Difficult to Bet Against Canada's Marijuana Boom|
www.bloomberg.com - December 14 at 9:04 AM
|Canada Gives Provinces Bigger Cut of Pot Tax From Legalization|
www.bloomberg.com - December 12 at 9:26 AM
|Ehave Expands into the Cannabis Industry -- CFN Media|
finance.yahoo.com - December 5 at 9:22 AM
|Eight Capital Boosts MedReleaf Corp. (LEAF) Price Target to C$20.00|
www.americanbankingnews.com - November 15 at 3:00 PM
|Canopy Growth’s second-quarter loss dampens marijuana stock rally|
www.theglobeandmail.com - November 15 at 4:03 AM
|BRIEF-Medreleaf announces $100.5 mln bought deal financing|
www.reuters.com - November 15 at 4:03 AM
|MedReleaf's Australian joint venture partner receives medical cannabis cultivation and production license from the Australian Office of Drug Control|
finance.yahoo.com - November 15 at 4:03 AM
|Canaccord Genuity Boosts MedReleaf Corp. (LEAF) Price Target to C$20.00|
www.americanbankingnews.com - November 14 at 2:30 PM
MedReleaf (TSE:LEAF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
MedReleaf (TSE LEAF) Stock Chart for Wednesday, March, 21, 2018